May 26, 2017
Agents Dennis Wichern and Daniel Gillen of the Federal Drug Enforcement Administration (DEA) spoke at the College on May 25 about the opioid epidemic in the United States.
The title of their talk was “Prescription Drug Updates and Medical Provider Safeguards.”
Special Agent-in-Charge Wichern manages the Chicago Field Division, covering Illinois, Indiana, Wisconsin, Minnesota, and North Dakota.
Gillen is Diversion Program Manager for the DEA’s Chicago Field Division.
Wichern is an expert on the prescription drug epidemic and on heroin addiction.
The duo speak to healthcare providers to identify methods to better safeguard their practices and reduce the professional and operational risks involved.
The agents covered methadone, naloxone, buprenorphine, fentanyl, heroin, and neonatal abstinence syndrome, and discussed provider safeguards, drug disposal options, and Federal and State laws regarding prescription medication.
United States Senator Dick Durbin in a visit to the College last fall expressed his great concern about the opioid epidemic in the United States. It was because of a request from Senator Durbin to Dean Clark Stanford that the College brought the agents in to discuss their important topic.
The agents also received a tour of the College from Dr. Susan Rowan, Associate Dean for Clinical Affairs, one of the members of the College leadership team who met with Senator Durbin at the College last fall.
Photo caption: DEA Agents Dennis Wichern and Daniel Gillen, receiving a tour of the College from Dr. Susan Rowan.